This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Merck Sharp + Dohme B.v.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovations of De Adrianus Petrus Antonius Man
Introduction
De Adrianus Petrus Antonius Man is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can be used in cancer treatment. His work exemplifies the intersection of chemistry and medicine, showcasing the potential of innovative compounds in addressing serious health issues.
Latest Patents
De Adrianus Petrus Antonius Man holds a patent for "Substituted thieno[2,3-b]pyrazine compounds as modulators of B-Raf kinase activity." This invention relates to compounds according to general Formula (I) or a pharmaceutically acceptable salt thereof. The compounds developed by Man can be utilized for the treatment of cancer, highlighting his commitment to advancing medical science.
Career Highlights
He is currently associated with Merck Sharp & Dohme B.V., a leading global healthcare company. His role at Merck Sharp & Dohme B.V. allows him to collaborate with other experts in the field and contribute to groundbreaking research and development in pharmaceuticals.
Collaborations
Some of his notable coworkers include Brigitte Johanna Bernita Folmer and Elisabeth Sophia Gernette. Their collaborative efforts in research and development have further enhanced the impact of their work in the pharmaceutical industry.
Conclusion
De Adrianus Petrus Antonius Man's innovative contributions to cancer treatment through his patented compounds demonstrate the vital role of inventors in advancing healthcare. His work continues to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile